GAMA
SILK

Graticule Asia Macro Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Graticule Asia Macro Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-52,565
Closed -$3.31M – 226
2020
Q4 		$3.31M Buy
+52,565
New +$3.26M 1.59% 20

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Graticule Asia Macro Advisors's SILK Position: Q1 2021 in Review

Graticule Asia Macro Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2021, closing a stake of 52,565 shares — an estimated $3.31M sold.

Graticule Asia Macro Advisors first reported a position in SILK in Q4 2020 and held it in 1 quarter. The position peaked at $3.31M in Q4 2020. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • Graticule Asia Macro Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 52,565 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $3.31M.
  • Graticule Asia Macro Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's Silk Road Medical, Inc. Common Stock position peaked at $3.31M in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on Graticule Asia Macro Advisors's 13F filing for Q1 2021, filed 17 May 2021.